Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

403

LikeLikedUnlike

166-180 of 191

Keys to Closing the Gender Gap in Stroke Trials
NeuroFrontiers
Keys to Closing the Gender Gap in Stroke Trials
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Cheryl Carcel, MD, PhD
  Peer
Diagnosing Mental Illness with the Perspectives Approach
NeuroFrontiers
Diagnosing Mental Illness with the Perspectives Approach
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Margaret Chisolm, MD
  Peer
Could T Cells Lead to New MS Treatments?
NeuroFrontiers
Could T Cells Lead to New MS Treatments?
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Shivashankar Othy, DVM, PhD
  Peer
Seeking Out Symptoms of Broken Heart Syndrome
NeuroFrontiers
Seeking Out Symptoms of Broken Heart Syndrome
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Ilan Wittstein, MD
  Peer
The Future of Restoring Functionality in Stroke Survivors
NeuroFrontiers
The Future of Restoring Functionality in Stroke Survivors
- David Weisman, MD
  Peer
- Mijail D Serruya MD,PhD
  Peer
Refocusing Our Efforts on Advancing Technology to Help Stroke Survivors
NeuroFrontiers
Refocusing Our Efforts on Advancing Technology to Help Stroke Survivors
- David Weisman, MD
  Peer
- Mijail D Serruya MD,PhD
  Peer
advertisement
Treatment of Progressive MS: Why, Who, When, How
Global Neurology Academy
Treatment of Progressive MS: Why, Who, When, How
- Giancarlo Comi, MD
  Peer
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Global Neurology Academy
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
- Prof. Ralf Gold
  Peer
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Global Neurology Academy
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Global Neurology Academy
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CE
The Diagnostic Challenges of Spinal Cord Lesions in MS
- Jiwon Oh, MD, PhD
  Peer
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Global Neurology Academy
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
advertisement
Reducing the Burden of MS Treatment
Global Neurology Academy
Reducing the Burden of MS Treatment
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Global Neurology Academy
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Multiple Sclerosis Physician Resources
Global Neurology Academy
Multiple Sclerosis Physician Resources